Hervé Girsault
Corporate Officer/Principal at NLS PHARMACEUTICS LTD.
Net worth: 3 300 $ as of 2024-04-29
Profile
Hervé Girsault founded Turos Capital AG in 2018, where he is working as Director from 2018.
Mr. Girsault also founded Synosia Therapeutics AG, where he worked as Director.
Mr. Girsault also currently works at NLS Pharmaceutics Ltd., as Head-Business Development from 2017.
Mr. Girsault also formerly worked at BioClinica, Inc., as Chief Executive Officer, Synexus Compass, Inc., as President & Chief Executive Officer from 2009 to 2010, Novartis Consumer Health SA, as Chief Executive Officer, Novartis Belux, as Chief Executive Officer, Nordic Bioscience A, as Director, Gerber Products Co., Inc., as General Manager from 1990 to 1995, Novartis International AG, as Head-Business Development, Inventages Venture Capital Investment, Inc, as Partner, Novartis Pharmaceuticals Corp., as Vice President, Coopers & Lybrand International, as Principal, Coopers & Lybrand Consulting, Inc., as Manager-Mergers & Acquisitions, and PIQUR Therapeutics AG, as Chief Business Officer.
Mr. Girsault received his Masters Business Admin degree in 1985 from Columbia Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NLS PHARMACEUTICS LTD.
0.06% | 2024-05-13 | 25,000 ( 0.06% ) | 3 300 $ | 2024-04-29 |
Hervé Girsault active positions
| Companies | Position | Start |
|---|---|---|
| NLS PHARMACEUTICS LTD. | Corporate Officer/Principal | 2017-11-30 |
| Turos Capital AG | Founder | 2017-12-31 |
Former positions of Hervé Girsault
| Companies | Position | End |
|---|---|---|
Synexus Compass, Inc.
 Synexus Compass, Inc. Medical/Nursing ServicesHealth Services Synexus Compass, Inc. provided medical image-analysis, subject-recruitment and biochemical marker services that enable life-science industry clients to execute clinical trials while decreasing the time, uncertainty and cost of product development. The company was founded in 1998 and was headquartered in San Francisco, CA. | Chief Executive Officer | 2010-03-16 |
Gerber Products Co., Inc.
 Gerber Products Co., Inc. Food: Specialty/CandyConsumer Non-Durables Gerber Products Co. manufactures and supplies baby foods and infant care items. The firm also makes baby cereal, juices and toddler food along with baby bath and skincare products, bottles, tethers, breastfeeding accessories, spill-proof cups, infant toys and clothing. The company was founded in 1928 and is headquartered in Fremont, MI. | Corporate Officer/Principal | 1994-12-31 |
| BIOCLINICA INC | Chief Executive Officer | - |
| Coopers & Lybrand Consulting, Inc. | Corporate Officer/Principal | - |
| Novartis Belux | Chief Executive Officer | - |
Training of Hervé Girsault
| Columbia Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NLS PHARMACEUTICS LTD. | Health Technology |
| Private companies | 14 |
|---|---|
Gerber Products Co., Inc.
Gerber Products Co., Inc. Food: Specialty/CandyConsumer Non-Durables Gerber Products Co. manufactures and supplies baby foods and infant care items. The firm also makes baby cereal, juices and toddler food along with baby bath and skincare products, bottles, tethers, breastfeeding accessories, spill-proof cups, infant toys and clothing. The company was founded in 1928 and is headquartered in Fremont, MI. | Consumer Non-Durables |
BioClinica, Inc.
 BioClinica, Inc. Medical/Nursing ServicesHealth Services BioClinica, Inc. engages in the provision of integrated and technology-enhanced clinical trial management services. It offers research network, eclinical solutions, randomization and trial supply management, medical imaging, and cardiac safety. The company was founded in 1990 and is headquartered in Princeton, NJ. | Health Services |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
Synosia Therapeutics AG
 Synosia Therapeutics AG Pharmaceuticals: MajorHealth Technology Synosia Therapeutics develops and intends to commercialize innovative products for unmet medical needs in psychiatry and neurology. The firm is working to extend the reach of marketed and clinical-stage compounds, acquired through strategic partnerships with Novartis, Roche and Syngenta, into new indications with significant potential. Founded in December 2005 and headquartered in Switzerland, Synosia is managed by a highly experienced management team with some 200 years of drug development experience. The company is backed by $62 million in funding from high-quality investors and has a rich portfolio of compounds. | Health Technology |
Synexus Compass, Inc.
Synexus Compass, Inc. Medical/Nursing ServicesHealth Services Synexus Compass, Inc. provided medical image-analysis, subject-recruitment and biochemical marker services that enable life-science industry clients to execute clinical trials while decreasing the time, uncertainty and cost of product development. The company was founded in 1998 and was headquartered in San Francisco, CA. | Health Services |
Novartis Consumer Health SA
 Novartis Consumer Health SA Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Novartis Consumer Health SA is a company based in Basel, Switzerland. | Health Technology |
Inventages Venture Capital Investment, Inc
 Inventages Venture Capital Investment, Inc Investment ManagersFinance Inventages Venture Capital Investment, Inc (Inventages Venture) is a venture capital firm founded in 2000 by Gunnar Carsten Weikert. The firm is headquartered in Nassau with an additional office in London. | Finance |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Coopers & Lybrand International
 Coopers & Lybrand International Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., Coopers & Lybrand International is a company based in Toronto, Canada. | Commercial Services |
| Coopers & Lybrand Consulting, Inc. | |
Nordic Bioscience A/S
 Nordic Bioscience A/S Miscellaneous Commercial ServicesCommercial Services Nordic Bioscience A/S engages in preclinical and clinical drug development. It specializes in precision medicine using biomarker technologies. The company was founded by Claus Henrik Christiansen and Bente Juel Riis in 1991 and is headquartered in Herlev, Denmark. | Commercial Services |
PIQUR Therapeutics AG
 PIQUR Therapeutics AG Pharmaceuticals: OtherHealth Technology PIQUR Therapeutics AG engages in development of anti-cancer drugs based on the inhibition. Its products include PQR309, PQR620 and PQR5xx. The company was founded by Bernd Giese, Vladimir Cmiljanovic, Andreas Emmenegger, Ralf Rosenow and Matthias Wymann in August 2011 and is headquartered in Basel, Switzerland. | Health Technology |
| Turos Capital AG | |
| Novartis Belux |
- Stock Market
- Insiders
- Hervé Girsault
